James Cassella

James Cassella

Corporate Officer/Principal at TREVI THERAPEUTICS, INC.

Net worth: - $ as of 2026-05-30

71 year
Health Technology
Consumer Services

Profile

James V.
Cassella
is currently Chief Development Officer at Trevi Therapeutics, Inc. since 2024.
Formerly, Chief Development Officer at Sun Pharmaceutical Industries, Inc. from 2023 to 2024.
Chief Development Officer & Senior Vice President at Concert Pharmaceuticals, Inc. from 2015 to 2023.
CSO, Executive VP-Research & Development at Alexza Pharmaceuticals, Inc. from 2013 to 2015.
Senior VP-Clinical Research & Development at Neurogen Corp.
from 1989 to 2004.
Assistant Professor at Oberlin College.
Education includes a doctorate from Dartmouth College and an undergraduate degree from the University of New Haven.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-05 0 ( -.--% ) - $ 2026-05-30

James Cassella active positions

CompaniesPositionStart
TREVI THERAPEUTICS, INC. Corporate Officer/Principal 2024-09-29

Former positions of James Cassella

CompaniesPositionEnd
Corporate Officer/Principal 2024-08-31
CONCERT PHARMACEUTICALS, INC. Corporate Officer/Principal 2023-02-28
ALEXZA PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 2015-01-28
Chief Tech/Sci/R&D Officer 2004-05-31
Corporate Officer/Principal -
See the detail of James Cassella's experience

Training of James Cassella

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. James Cassella
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!